Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Mupiravir. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115873055B enables safe scalable synthesis reducing hazardous reagents and improving supply chain reliability for antiviral drug manufacturing partners globally.
Patent CN117024496A reveals a one-pot method for Mupiravir intermediates. Achieves 99.9% purity with reduced solvent use and simplified downstream processing for supply chains.